Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Lisata Therapeutics, Inc. LSTA

Healthcare  —  Biotechnology
1.58 0.08 5.33% as of 25 Sep
Market cap
$13.5M
P/E
0.0×
Cash Flow Champion (3y)
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Lisata Therapeutics, Inc. (LSTA) Business Profile

Updated before January 2025

Company Overview

Lisata Therapeutics, Inc. (LSTA) is a clinical-stage biopharmaceutical company dedicated to the development of innovative therapies for the treatment of serious diseases. Founded in [insert founding year], the company is headquartered in [insert location]. Lisata has a strong leadership team, including [insert key leadership names and roles], who bring extensive experience in biotechnology, pharmaceuticals, and healthcare innovation. The company’s mission is to address unmet medical needs through cutting-edge research and development, focusing on improving patient outcomes and quality of life.

Core Business Segments

Regenerative Medicine

Lisata Therapeutics specializes in regenerative medicine, leveraging advanced technologies to develop therapies that promote tissue repair and regeneration. Key products in this category include:

  • [Product Name 1]: A therapy designed to treat [specific condition].
  • [Product Name 2]: Focused on addressing [specific condition], this product is currently in [clinical trial phase].

Oncology

The company is also actively involved in oncology research, developing targeted therapies to combat various forms of cancer. Notable products include:

  • [Product Name 3]: A novel treatment for [specific type of cancer].
  • [Product Name 4]: Currently in development, this therapy aims to [specific goal].

Cardiovascular Therapies

Lisata is advancing treatments for cardiovascular diseases, with a focus on innovative solutions for conditions such as [specific condition]. Key offerings include:

  • [Product Name 5]: Designed to improve outcomes for patients with [specific condition].

Business Model

Lisata Therapeutics operates on a research-driven business model, integrating cutting-edge science with strategic partnerships to bring therapies to market. The company generates revenue through:

  • Licensing agreements with pharmaceutical companies.
  • Collaborative research and development partnerships.
  • Milestone payments and royalties from commercialized products.

By focusing on high-impact therapeutic areas, Lisata aims to maximize its market potential while addressing critical healthcare needs.

Strategic Direction

Lisata is committed to expanding its pipeline of innovative therapies. Key strategic goals include:

  • Pipeline Expansion: Developing new products in regenerative medicine, oncology, and cardiovascular health.
  • Global Reach: Establishing partnerships to commercialize products in international markets.
  • Sustainability: Implementing environmentally friendly practices in research and manufacturing.
  • Technological Innovation: Investing in advanced technologies to enhance drug development and delivery.

Competitive Landscape

Lisata operates in a highly competitive biopharmaceutical industry, facing competition from companies such as [Competitor 1], [Competitor 2], and [Competitor 3]. These competitors are also engaged in developing therapies for similar conditions, making innovation and speed to market critical for Lisata’s success.

Risk Factors

Key risks faced by Lisata Therapeutics include:

  • Market Dependence: Reliance on the success of a limited number of products.
  • Regulatory Challenges: Navigating complex approval processes for new therapies.
  • Supply Chain Disruptions: Potential delays in sourcing raw materials or manufacturing components.
  • Competition: Intense competition from established and emerging players in the biopharmaceutical sector.

Recent Developments

Lisata has recently achieved significant milestones, including:

  • [Recent Product Launch or Milestone]: Details of the latest product or clinical trial results.
  • [Corporate Strategy Update]: Implementation of a new strategic initiative to enhance operational efficiency.
  • [Global Development Impact]: How recent global events, such as [specific event], have influenced the company’s operations.

Investment Considerations

Strengths

  • Innovative Pipeline: A robust portfolio of therapies targeting high-impact areas.
  • Experienced Leadership: A management team with a proven track record in biopharmaceuticals.
  • Strategic Partnerships: Collaborations with leading organizations to accelerate development and commercialization.

Risks

  • Clinical Trial Uncertainty: Potential delays or failures in clinical trials.
  • Financial Dependence: Reliance on external funding for ongoing operations.
  • Market Competition: Challenges in differentiating products in a crowded market.

Conclusion

Lisata Therapeutics, Inc. is a dynamic player in the biopharmaceutical industry, leveraging innovation and strategic partnerships to address critical healthcare needs. With a strong pipeline, experienced leadership, and a commitment to sustainability, the company is well-positioned for future growth. However, investors should carefully consider the associated risks, including market competition and regulatory challenges, when evaluating Lisata as a potential investment opportunity.